DE602005026287D1 - ANTI-GLUTEN-YELLOW ANTIBODY FOR THE TREATMENT OF ZOELIAKIE - Google Patents

ANTI-GLUTEN-YELLOW ANTIBODY FOR THE TREATMENT OF ZOELIAKIE

Info

Publication number
DE602005026287D1
DE602005026287D1 DE602005026287T DE602005026287T DE602005026287D1 DE 602005026287 D1 DE602005026287 D1 DE 602005026287D1 DE 602005026287 T DE602005026287 T DE 602005026287T DE 602005026287 T DE602005026287 T DE 602005026287T DE 602005026287 D1 DE602005026287 D1 DE 602005026287D1
Authority
DE
Germany
Prior art keywords
gluten
zoeliakie
treatment
egg
yellow antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005026287T
Other languages
German (de)
Inventor
Hoon Sunwoo
Jeong S Sim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Alberta
Original Assignee
University of Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Alberta filed Critical University of Alberta
Publication of DE602005026287D1 publication Critical patent/DE602005026287D1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Compositions, food products or beverages for ameliorating the symptoms of celiac disease or gluten sensitive enteropathy comprising egg yolk antibodies against gluten, including gliadin, high molecular glutenin, low molecular glutenin and mixtures of the peptides. The antibodies may be produced by immunizing egg laying fowl with immunogenic preparations of gluten and harvesting the eggs and egg yolks.
DE602005026287T 2004-04-16 2005-04-18 ANTI-GLUTEN-YELLOW ANTIBODY FOR THE TREATMENT OF ZOELIAKIE Active DE602005026287D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52139404P 2004-04-16 2004-04-16
PCT/CA2005/000593 WO2005099753A1 (en) 2004-04-16 2005-04-18 Anti-gluten egg yolk antibodies for the treatment of celiac disease

Publications (1)

Publication Number Publication Date
DE602005026287D1 true DE602005026287D1 (en) 2011-03-24

Family

ID=35149778

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005026287T Active DE602005026287D1 (en) 2004-04-16 2005-04-18 ANTI-GLUTEN-YELLOW ANTIBODY FOR THE TREATMENT OF ZOELIAKIE

Country Status (6)

Country Link
US (1) US7854942B2 (en)
EP (1) EP1765395B1 (en)
AT (1) ATE497782T1 (en)
CA (1) CA2561800C (en)
DE (1) DE602005026287D1 (en)
WO (1) WO2005099753A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071101B2 (en) * 2005-11-03 2011-12-06 Avaxia Biologics, Inc. Antibody therapy for treatment of diseases associated with gluten intolerance
US8883133B2 (en) 2005-11-14 2014-11-11 Valorisation-Recherche Limited Partnership Pharmaceutical compositions comprising polymeric binders with non-hydrolysable their use in treating celiac disease
EP2076286B1 (en) * 2006-10-25 2016-03-09 Wisconsin Alumni Research Foundation Methods of reducing phosphate absorption using an anti-npt2b antibody
US8282928B2 (en) 2007-05-30 2012-10-09 The Governors Of The University Of Alberta Anti-gluten egg yolk antibodies for the treatment of celiac disease
WO2009020748A2 (en) 2007-07-16 2009-02-12 Avaxia Biologics, Inc. Antibody therapy for modulating function of intestinal receptors
WO2009046168A1 (en) 2007-10-02 2009-04-09 Avaxia Biologics, Inc. Antibody therapy for use in the digestive tract
US9028827B2 (en) * 2010-08-03 2015-05-12 Asia Hepato Gene Co. Compositions and methods for treating hepatitis virus infection
KR101024297B1 (en) * 2010-08-11 2011-03-29 유익종 Egg with reduced antigenicity of egg proteins by sodium lactate, heat treatment and lactic acid fermentation and producing method for the same
JP6652353B2 (en) * 2015-09-09 2020-02-19 任天堂株式会社 Communication device and battery lid
WO2017089873A1 (en) * 2015-11-27 2017-06-01 Telefonaktiebolaget Lm Ericsson (Publ) Method and system for multi-protocol transmissions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4550019A (en) * 1978-03-22 1985-10-29 South Africa Inventions Development Corporation Manufacture and use of fowl egg antibodies
US4357272A (en) * 1978-03-22 1982-11-02 The South African Inventions Development Corporation Recovering purified antibodies from egg yolk
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US5849349A (en) * 1982-06-03 1998-12-15 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
CH0225254H1 (en) * 1985-11-25 1998-09-15 Ghen Corp Specific antibody-containing substance from eggs and method of production and use thereof
US5367054A (en) * 1993-04-12 1994-11-22 Stolle Research & Development Corp. Large-scale purification of egg immunoglobulin
AU729502B2 (en) * 1996-10-02 2001-02-01 Ovimmune, Inc. Oral administration of chicken yolk antibodies to treat disease
EP0905518A1 (en) 1997-09-23 1999-03-31 Academisch Ziekenhuis Leiden Peptides specific for gluten-sensitive T-cells and use thereof
GB9814892D0 (en) * 1998-07-10 1998-09-09 Kennedy Rheumatology Inst Treatment of celiac disease
GB0212885D0 (en) 2002-06-05 2002-07-17 Isis Innovation Therapeutic epitopes and uses thereof

Also Published As

Publication number Publication date
EP1765395B1 (en) 2011-02-09
CA2561800A1 (en) 2005-10-27
CA2561800C (en) 2011-10-18
EP1765395A4 (en) 2008-06-18
US20080003263A1 (en) 2008-01-03
ATE497782T1 (en) 2011-02-15
WO2005099753A1 (en) 2005-10-27
US7854942B2 (en) 2010-12-21
EP1765395A1 (en) 2007-03-28

Similar Documents

Publication Publication Date Title
DE602005026287D1 (en) ANTI-GLUTEN-YELLOW ANTIBODY FOR THE TREATMENT OF ZOELIAKIE
Kovacs-Nolan et al. Immunochemical and structural analysis of pepsin-digested egg white ovomucoid
Liu et al. Allergenicity and oral tolerance of enzymatic cross-linked tropomyosin evaluated using cell and mouse models
ATE478567T1 (en) BABY FOOD WITH HYDROLIZED PROTEINS
CY1114855T1 (en) ANTIBODIES AND PARTS COMING FROM THESE BINDING TO PROTEINS TOY STEAP-1
Ahmed et al. Immunomodulatory effect of laccase/caffeic acid and transglutaminase in alleviating shrimp tropomyosin (Met e 1) allergenicity
Fei et al. Assessment of the sensitizing capacity and allergenicity of enzymatic cross‐linked arginine kinase, the crab allergen
AU2016343738B2 (en) Methods for determination of bioactivity, quantity, removal, or inactivation of cereal amylase trypsin inhibitors in cereals, flours, plants, and complex foods
EA200700136A1 (en) ANTI-CD154-ANTIBODIES
WO2009034315A3 (en) Vaccine
WO2007052059A3 (en) Changing th1/th2 balance in split influenza vaccines with adjuvants
DE69837337D1 (en) PREPARATION OF PROTEINS IN EGGS
Ahmed et al. Enzymatic crosslinking and food allergenicity: A comprehensive review
TR201905375T4 (en) Vicia faba protein food products.
MX2009007572A (en) Fusion protein.
EA200100668A1 (en) INDUCED BY FOOD, ANTI-SECRETORAL PROTEINS IN THE EGG YELLOW
Kazem-Farzandi et al. β-lactoglobulin mutation Ala86Gln improves its ligand binding and reduces its immunoreactivity
JP2014171424A (en) Manufacturing method of egg white material with selectively reduced ovomucoid allergen
WO2015168416A1 (en) Methods for determination of bioactivity, removal, or inactivation cereal amylase trypsin inhibitors in cereals, flours and complex foods
EP3947412A4 (en) Deflavored egg protein isolate, products made with protein isolates and methods of making same
Peñas et al. Clinical monosensitivity to salmon and rainbow trout: a case report.
Hirose et al. Oligoclonal enzyme-linked immunosorbent assay capable of determining the major food allergen, ovomucoid, irrespective of the degree of heat denaturation
Zhang et al. Detoxification of wheat gluten by enzymatic transamidation under reducing condition and its application in typical food model
Castro et al. Proteomic analysis of food allergens
Kondo et al. Comparison of allergenic properties of salmon (Oncorhynchus nerka) between landlocked and anadromous species